Many studies have shown that the actin cytoskeleton plays an essential role in the initiation
and progression of cancer. As an actin‐binding protein, Twinfilin1 (TWF1) plays an important …

Simple Summary Genome-based cancer medicine is becoming the standard of care: the
patient's tumor DNA is first analyzed to identify driver mutations, and this permits later …

Metal compounds, especially gold complexes, have recently gained increasing attention as
possible lung cancer therapeutics. Some gold complexes display not only excellent activity …

Radiation resistance is an obstacle to the successful treatment of lung cancer. Metformin, a
first-line antidiabetic drug, has been studied for its potential use in radiotherapy, as several …

Lung cancer has the highest mortality rate amongst all malignancies worldwide, and is the
second-highest incidence of cancer in women. Non-small cell lung cancer (NSCLC) is …

Background Novel therapeutic targets are urgently needed for treating drug-resistant non-
small cell lung cancer (NSCLC) and overcoming drug resistance to molecular-targeted …

Despite recent developments in separation techniques, the analysis of relatively small highly
polar negatively charged analytes (eg small organic acids, phosphorylated sugars, and …

Objective: This study evaluated the efficacy and safety of the gemcitabine and oxaliplatin
intrathoracic perfusion chemotherapy (IPCGOR) regimen combined with interleukin-2 (IL-2) …

The third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-
TKIs), osimertinib, aumolertinib, and furmonertinib represent a new treatment option for …

Non‐small cell lung cancer (NSCLC) patients are often elderly or unfit and thus cannot
tolerate standard aggressive therapy regimes. In our study, we test the efficacy of the DNA …